Ocuphire Pharma Inc (OCUP) stock is lower by -40.24% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives OCUP stock a score of 71 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 75. OCUP's rank also includes a fundamental score of 72. In addition to the average rating from Wall Street analysts, OCUP stock has a mean target price of $24.33. This means analysts expect the stock to rise 603.27% over the next 12 months. The long-term technical score for OCUP is 66.
Ocuphire Pharma Inc (OCUP) Stock Decreases -9.42% This Week; Should You Buy?
OCUP has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on OCUP!